Your browser doesn't support javascript.
Clinical illness with viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) virus presenting 72 days after infection in an immunocompromised patient.
Hughes, Carly M; Gregory, Gareth P; Pierce, Anna B; Druce, Julian D; Catton, Mike; Chong, Brian; Sherry, Norelle L; Graham, Maryza; Chen, Melissa; Salvaris, Ross; Eise, Nicole; Lee, Jean Y H; McQuilten, Zoe; Crouch, Simon; Looker, Clare; Korman, Tony M; Stuart, Rhonda L.
  • Hughes CM; Monash Infectious Diseases, Monash Health, Clayton, Victoria, Australia.
  • Gregory GP; Department of Microbiology, Monash Pathology, Monash Health, Clayton, Victoria, Australia.
  • Pierce AB; Monash Haematology, Monash Health, Clayton, Victoria, Australia.
  • Druce JD; Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
  • Catton M; Monash Infectious Diseases, Monash Health, Clayton, Victoria, Australia.
  • Chong B; Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
  • Sherry NL; South Eastern Public Health Unit, Monash Health, Clayton, Victoria, Australia.
  • Graham M; Infectious Diseases Unit, Alfred Hospital, Melbourne, Victoria, Australia.
  • Chen M; Victorian Infectious Diseases Reference Laboratory, The University of Melbourne at The Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Salvaris R; Victorian Infectious Diseases Reference Laboratory, The University of Melbourne at The Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Eise N; Victorian Infectious Diseases Reference Laboratory, The University of Melbourne at The Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Lee JYH; Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • McQuilten Z; Monash Infectious Diseases, Monash Health, Clayton, Victoria, Australia.
  • Crouch S; Department of Microbiology, Monash Pathology, Monash Health, Clayton, Victoria, Australia.
  • Looker C; Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
  • Korman TM; Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Stuart RL; Monash Haematology, Monash Health, Clayton, Victoria, Australia.
Infect Control Hosp Epidemiol ; 43(6): 820-822, 2022 06.
Article in English | MEDLINE | ID: covidwho-1279734
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Virus Diseases / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Infect Control Hosp Epidemiol Journal subject: Communicable Diseases / Nursing / Epidemiology / Hospitals Year: 2022 Document Type: Article Affiliation country: Ice.2021.120

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Virus Diseases / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Infect Control Hosp Epidemiol Journal subject: Communicable Diseases / Nursing / Epidemiology / Hospitals Year: 2022 Document Type: Article Affiliation country: Ice.2021.120